Table 1 Antibacterial spectrum of ILE and ILF
Strains or drug combinations | ILE MIC (µg mL−1) | ILF MIC (µg mL−1) | FICI |
|---|---|---|---|
AlRa | 0.05a | 1.25a | – |
AlRv | 0.05a | ND | – |
AlMsm | 0.0625a | 2.5a | – |
AlMab | 1a | 20a | – |
AlMmr | 0.08a | 0.625a | – |
H37Rv | 0.025b | 2.5b | – |
K11c | 0.025–0.05b | ND | – |
K12c | 0.025b | ND | – |
K13c | 0.01b | ND | – |
K14c | 0.01b | ND | – |
K16c | 0.05b | ND | – |
K17c | 0.01b | ND | – |
K18c | 0.025–0.05b | ND | – |
K19c | 0.01b | ND | – |
K20c | 0.05b | ND | – |
Staphylococcus aureus | >128 | >128 | – |
Acinetobacter baumannii | >128 | >128 | – |
Enterococcus faecium | >128 | >128 | – |
Klebsiella pneumoniae | >128 | >128 | – |
Pseudomonas aeruginosa | >128 | >128 | – |
ILE + RIF | – | – | 0.3125a |
ILE + INH | – | – | 0.625a |
ILE + EMB | – | – | 0.5625a |
ILE + STR | – | – | 1a |
ILE + CFZ | – | – | 1a |
ILE + BDQ | – | – | 0.62a |
ILE + TB47 | – | – | 0.3125a |
ILF + RIF | – | – | 1.0625a |
ILF + INH | – | – | 0.3125a |
ILF + EMB | – | – | 1a |
ILF + STR | – | – | 1a |
ILF + CFZ | – | – | 0.63a |
ILF + BDQ | – | – | 1a |
ILF + TB47 | – | – | 0.3125a |